JPWO2019201192A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019201192A5 JPWO2019201192A5 JP2020557325A JP2020557325A JPWO2019201192A5 JP WO2019201192 A5 JPWO2019201192 A5 JP WO2019201192A5 JP 2020557325 A JP2020557325 A JP 2020557325A JP 2020557325 A JP2020557325 A JP 2020557325A JP WO2019201192 A5 JPWO2019201192 A5 JP WO2019201192A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cvb1
- modified
- cancer
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810338046.2 | 2018-04-16 | ||
| CN201810338046.2A CN110387353B (zh) | 2018-04-16 | 2018-04-16 | 一种用于治疗肿瘤的柯萨奇b组病毒 |
| PCT/CN2019/082608 WO2019201192A1 (zh) | 2018-04-16 | 2019-04-15 | 一种用于治疗肿瘤的柯萨奇b组病毒 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021522190A JP2021522190A (ja) | 2021-08-30 |
| JPWO2019201192A5 true JPWO2019201192A5 (https=) | 2022-04-19 |
| JP2021522190A5 JP2021522190A5 (https=) | 2022-04-19 |
| JP7336791B2 JP7336791B2 (ja) | 2023-09-01 |
Family
ID=68240424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020557325A Active JP7336791B2 (ja) | 2018-04-16 | 2019-04-15 | 腫瘍を治療するためのコクサッキーウイルスｂ群 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210154249A1 (https=) |
| EP (1) | EP3783100A4 (https=) |
| JP (1) | JP7336791B2 (https=) |
| KR (1) | KR102768669B1 (https=) |
| CN (1) | CN110387353B (https=) |
| AU (1) | AU2019254948B2 (https=) |
| CA (1) | CA3097306A1 (https=) |
| WO (1) | WO2019201192A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114514323A (zh) * | 2019-08-05 | 2022-05-17 | 复诺健生物科技加拿大有限公司 | 遗传修饰的肠病毒载体 |
| CN116751288A (zh) * | 2020-04-26 | 2023-09-15 | 北京万泰生物药业股份有限公司 | 针对柯萨奇病毒b1型的单克隆抗体及其用途 |
| CN118086228A (zh) * | 2022-11-28 | 2024-05-28 | 厦门大学 | 用于治疗肿瘤的柯萨奇b组1型病毒 |
| CN116769733B (zh) * | 2023-08-02 | 2023-11-03 | 中国医学科学院医学生物学研究所 | 一种柯萨奇病毒b组4型毒株及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101065144B (zh) | 2004-08-20 | 2012-06-13 | 溶瘤病毒有限公司 | 治疗血液癌症的方法和组合物 |
| EP2125032A4 (en) | 2007-02-20 | 2011-02-23 | Mayo Foundation | CANCER TREATMENT WITH VIRAL NUCLEIC ACID |
| KR101942237B1 (ko) | 2011-01-04 | 2019-01-25 | 신라젠(주) | 종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산 |
| JP2016500108A (ja) | 2012-11-21 | 2016-01-07 | デューク ユニバーシティー | ヒトの腫瘍のための腫瘍溶解性ポリオウイルス |
| JP6396891B2 (ja) * | 2013-04-17 | 2018-09-26 | 新日本製薬株式会社 | 遺伝子改変コクサッキーウイルス |
| CN103981152B (zh) | 2014-04-16 | 2015-01-21 | 武汉博威德生物技术有限公司 | 一种柯萨奇病毒及其制备抗肿瘤药物之应用 |
| AU2015289081B2 (en) | 2014-07-16 | 2020-02-06 | Transgene Sa | Combination of oncolytic virus with immune checkpoint modulators |
| EP4023233B1 (en) * | 2016-09-27 | 2026-01-07 | Sator Therapeutics LLC | Optimized oncolytic viruses and uses thereof |
| CN109568350B (zh) * | 2017-09-29 | 2023-02-03 | 厦门大学 | 一种用于治疗肿瘤的柯萨奇病毒 |
-
2018
- 2018-04-16 CN CN201810338046.2A patent/CN110387353B/zh active Active
-
2019
- 2019-04-15 JP JP2020557325A patent/JP7336791B2/ja active Active
- 2019-04-15 WO PCT/CN2019/082608 patent/WO2019201192A1/zh not_active Ceased
- 2019-04-15 CA CA3097306A patent/CA3097306A1/en active Pending
- 2019-04-15 EP EP19788373.9A patent/EP3783100A4/en active Pending
- 2019-04-15 US US17/047,783 patent/US20210154249A1/en active Pending
- 2019-04-15 AU AU2019254948A patent/AU2019254948B2/en active Active
- 2019-04-15 KR KR1020207033014A patent/KR102768669B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6419706B2 (ja) | ミニプロモーターカセットを含むレトロウイルスベクター | |
| JP2020528890A5 (https=) | ||
| Callegari et al. | Anti-tumor activity of a miR-199-dependent oncolytic adenovirus | |
| JP2021522190A5 (https=) | ||
| US20250059564A1 (en) | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer | |
| CN110387353B (zh) | 一种用于治疗肿瘤的柯萨奇b组病毒 | |
| US20040126785A1 (en) | Metastatic colon cancer specific promoter and uses thereof | |
| TWI545196B (zh) | Ｒｅｉｃ表現腺病毒載體 | |
| JP2012515532A (ja) | Ｍｉｒ−２１プロモーター駆動性標的がん治療 | |
| Qu et al. | Inhibitory effect of biosynthetic nanoscale peptide Melittin on hepatocellular carcinoma, driven by survivin promoter | |
| CN109568350B (zh) | 一种用于治疗肿瘤的柯萨奇病毒 | |
| Shen et al. | Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene | |
| JPWO2019201192A5 (https=) | ||
| CN115989321B (zh) | 病毒制剂、用于配制病毒制剂的溶液及其用途 | |
| WO2003006640A1 (en) | A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it | |
| JP2020537534A5 (https=) | ||
| WO2021233849A1 (en) | Viral vectors and nucleic acids for regulated gene therapy | |
| WO2016187908A1 (zh) | 重组溶瘤腺病毒及其应用 | |
| WO2024114576A1 (zh) | 用于治疗肿瘤的柯萨奇b组1型病毒 | |
| US11951141B2 (en) | Replication-enhanced oncolytic adenoviruses | |
| WO2019037642A1 (zh) | 一种用于治疗肿瘤的埃可病毒 | |
| AU2019359505B2 (en) | A method to treat disease using a nucleic acid vector encoding a highly compact multi-input logic gate | |
| EP3822355A1 (en) | Anti-tumor composition | |
| JP7406263B2 (ja) | 改変アデノウイルス及びこれを含む医薬 | |
| EP1156118A1 (en) | Virus vector |